Smart Life Sciences Manufacturing Market Size & Share Report 2033

report image

Smart Life Sciences Manufacturing Market Forecast to 2033 - COVID-19 Impact and Global Analysis by Component (Solutions and Services), Technology [AR/VR Systems, Internet of Things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and Others], and Application (Pharma, Bio-Pharma, and Medical Device)

Publication Month: Mar 2023 | Report Code: TIPRE00029832 | No. of Pages: 212 | Category: Technology, Media and Telecommunications | Status: Published

The smart life sciences manufacturing market is projected to reach US$ 78,974.61 million by 2033 from US$ 18,649.50 million in 2022; it is expected to record a CAGR of 14.4% during 2023–2033.

The life sciences manufacturing process has changed significantly over the past ten years. Life science manufacturing is a complex process. A smart factory concept that interconnects machinery and system on the production site can simplify the manufacturing process. The system is also connected to the client, partner, and production site. After COVID-19 pandemic, many pharma and medical device manufacturers started to adopt pharma 4.0 esp. due to rising regulations and inspection concerns. Smart life sciences manufacturing, often known as Pharma 4.0, aims to provide practical guidance, embed regulatory best practices, and accelerate Pharma 4.0 transformations. The main goal is to allow organizations participating in the pharmaceutical product lifecycle to control the full potential of digitalization and provide faster therapeutic innovations & improved production processes for the benefit of end-users. These changes will bring huge opportunities to life science manufacturers in the coming years. Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and understand the most effective ways to achieve their goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Such factors are expected to boost the smart life sciences manufacturing market size strongly in the coming years.

Smart Life Sciences Manufacturing Market - Strategic Insights

Report Coverage - Smart Life Sciences Manufacturing Market
Report CoverageDetails
Market Size Value inUS$ 18,649.50 million in 2022
Market Size Value byUS$ 78,974.61 million by 2033
Growth rateCAGR of 14.4% from 2023 to 2033
Forecast Period2023-2033
Base Year2022
No. of Pages212
No. of Tables84
No. of Charts & Figures66
Historical data availableYes
Segments coveredComponent, Technology, and Application
Free Sample Copy Available

Lucrative Regions for Smart Life Sciences Manufacturing Market

Lucrative Regions for Smart Life Sciences Manufacturing Market

Get more information on this report :

Market Insights – Smart Life Sciences Manufacturing Market

The pharmaceutical segment is a key contributor to the global industrial sector. Moreover, the demand and sales of medicine are increasing every day. Thus, pharmaceutical manufacturing businesses invest huge amounts of economic resources in R&D for bringing innovations to markets. Technology upgrades are the key to tackling future manufacturing problems. With this, the Pharma 4.0 market is gaining huge attention worldwide. In June 2022, GSK, a British Big Pharma, inaugurated its new aseptic smart manufacturing plant in Barnard Castle, England. This fully automated plant leverages digitalization to streamline the manufacturing process. This, in turn, would allow GSK to accelerate the launch of new medicines while cutting down on waste. In December 2020, Bayer AG announced the launch of a Cell and Gene Therapy Platform within its Pharmaceuticals division. This platform will combine multiple backbone functions for providing support across the entire value chain of the research and development of cell and gene therapies. In November 2020, the UK started building a “factory of the future” to renovate small-molecule drug production. Drugmakers, academic institutions, healthcare providers, and regulators are expected to come together at the facility to test and improve new technologies, including continuous, digital, and autonomous manufacturing. Hence, the growing adoption of digital transformation is expected to boost the smart life sciences manufacturing market size.

Component-Based Insights

The smart life sciences manufacturing market, by component, is bifurcated into solutions and services. The solutions segment is expected to hold a larger smart life sciences manufacturing market share during the forecast period, despite recording slower growth rates than the services segment. The pharmaceutical industry is rapidly adopting digital transformation as digitalization brings flexibility and efficiency to processes. With the growing complexity of production systems and processes, establishing interconnectivity and deploying robust smart factory solutions in line with good manufacturing practices (GMP) have become a strategic priority for life sciences companies. Moreover, Industry 4.0 has simplified the process of accessing operations data, along with enabling businesses to meet targeted key performance indicators (KPIs). Smart manufacturing solutions assist in quality management by monitoring the temperature and humidity of inventory, monitoring end-to-end process visibility, enhancing product consistency, and identifying specific issues related to batch manufacturing.  The life science industry engages in developing novel, effective, quality, and precise treatments. Pioneers in the industry are exploring new therapeutic areas and approaches by harnessing the latest technological advancements to gain a competitive edge. Such factors drive the smart life sciences manufacturing market growth for the solutions segment.

The smart life sciences manufacturing market is segmented on the basis of component, technology, and application. Based on component, the market is bifurcated into solutions and services. By technology, the smart life sciences manufacturing market is segmented into Augmented Reality/Virtual Reality (AR/VR) systems, Internet of Things (IoT), artificial intelligence (AI), cybersecurity, big data, and others. IoT segment commanded the largest smart life sciences manufacturing market share in 2022. Based on application, the smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical device. Based on geography, the smart life sciences manufacturing market is primarily segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South America (SAM). ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, IBM Corporation, Rockwell Automation, Siemens AG, and Sophos Group plc are among the key smart life sciences manufacturing market players.

Smart life sciences manufacturing market players mainly focus on partnerships to create customer value.

  • In February 2023, Theragent, a cell therapy CDMO focused on advancing next-generation cancer and rare disease treatments, signed a multi-year exclusive contract with Insight68, an AI-driven software provider that aims to digitalize and streamline the cell therapy manufacturing process. The partnership reinforces Theragent's commitment to 100% digital batch record compliance and elevates the company's reputation as a leading CDMO in the current biopharma manufacturing transformation.
  • In December 2022, Hovione announced a strategic collaboration with GEA for Advance Continuous Tableting. Hovione is a company engaged in industrializing and democratizing emerging pharmaceutical technologies. It offers amorphous solid spray-dried dispersions converted into dependable and scalable offerings, made available to all.

Frequently Asked Questions

The global smart life sciences manufacturing market was estimated to be US$ 18,649.50 million in 2022 and is expected to grow at a CAGR of 14.4%, during the forecast period 2023 - 2033.
Smart life sciences manufacturing market is being driven by the growing adoption of Pharma 4.0. Additionally, rising application of advanced technologies in cancer research is expected to provide growth opportunities for the smart life sciences manufacturing market.
The connection of data silos is increasing, which is likely to result in better access to insights and data leads. Additionally, there is an increasing usage of blockchain, coupled with roadmaps been created for Pharma 5.0.
The key players, holding majority shares, in smart life sciences manufacturing market includes ABB Ltd, Emerson Electric Co, General Electric Co, Honeywell International Inc, and Rockwell Automation.
Asia Pacific is the fastest growing regional market, followed by Europe.
India, China, and Germany are expected to register high growth rates during the forecast period.
The US held the largest market share in 2022, followed by China.
The solutions segment led the smart life sciences manufacturing market with a significant share in 2022.
The smart life sciences manufacturing market is expected to reach US$ 78.974.61 million by 2033.
The incremental growth, expected to be recorded for the smart life sciences manufacturing market during the forecast period, is US$ 58,475.08 million.

The List of Companies - Smart Life Sciences Market 

  1. ABB Ltd
  2. Bosch Rexroth AG
  3. Emerson Electric Co
  4. Fortinet Inc
  5. General Electric Co
  6. Honeywell International Inc
  7. IBM Corporation
  8. Rockwell Automation
  9. Siemens AG
  10. Sophos Group plc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the smart life sciences manufacturing market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations such as specific country and segmental insight highlights crucial progressive industry trends in the smart life sciences manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount